Publicacións (8) Publicacións de Guillermo José Prada Ramallal

2021

  1. Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study

    Infectious Diseases and Therapy, Vol. 10, Núm. 1, pp. 347-362

  2. Offering, participation and adherence to cardiac rehabilitation programmes in the elderly: a European comparison based on the EU-CaRE multicentre observational study

    European journal of preventive cardiology, Vol. 28, Núm. 5, pp. 558-568

  3. Steroid-resistant graves’ orbitopathy treated with tocilizumab in real-world clinical practice: A 9-year single-center experience

    Journal of Clinical Medicine, Vol. 10, Núm. 4, pp. 1-18

2019

  1. Bias in pharmacoepidemiologic studies using secondary health care databases: A scoping review

    BMC Medical Research Methodology, Vol. 19, Núm. 1

2018

  1. Primary versus secondary source of data in observational studies and heterogeneity in meta-analyses of drug effects: A survey of major medical journals

    BMC Medical Research Methodology, Vol. 18, Núm. 1

2017

  1. Diverging Conclusions from the Same Meta-Analysis in Drug Safety: Source of Data (Primary Versus Secondary) Takes a Toll

    Drug Safety, Vol. 40, Núm. 4, pp. 351-358

  2. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: Systematic review and meta-Analysis

    Gut, Vol. 66, Núm. 8, pp. 1474-1486

  3. Summarising the Evidence for Drug Safety: A Methodological Discussion of Different Meta-Analysis Approaches

    Drug Safety, Vol. 40, Núm. 7, pp. 547-558